INTERVIEW: QuantuMDx aims to be Apple of diagnostic industry's eye
This article was originally published in Clinica
As far as aspirations go, QuantuMDx is setting its sights high. The UK diagnostics start-up is still in the early stages of product development but one thing CEO Elaine Warburton has set her mind on is ensuring the company’s “lab-in-your-hand” device will emulate the sleek, simple and user-friendly designs that are iconic of the information technology giant Apple.
You may also be interested in...
The COVID-19 pandemic has accelerated development of another new molecular diagnostic technology.
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.